Drug Profile
CPBI 402 - Corepharmbio
Alternative Names: CPBI-402Latest Information Update: 28 Apr 2018
Price :
$50
*
At a glance
- Originator Corepharmbio
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Genitourinary disorders
Most Recent Events
- 28 Apr 2018 No recent reports of development identified for phase-I development in Genitourinary-disorders(In volunteers) in South Korea (PO, Tablet)